scholarly article | Q13442814 |
P819 | ADS bibcode | 2009PNAS..106.1524I |
P356 | DOI | 10.1073/PNAS.0812247106 |
P932 | PMC publication ID | 2635812 |
P698 | PubMed publication ID | 19168629 |
P5875 | ResearchGate publication ID | 23938941 |
P50 | author | Ralph Steinman | Q105494 |
Chae Gyu Park | Q42322699 | ||
Juliana Idoyaga | Q91877870 | ||
Nao Suda | Q125217142 | ||
P2093 | author name string | Koji Suda | |
P2860 | cites work | Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules | Q22011207 |
In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas | Q24652833 | ||
Dendritic cells in the T-cell areas of lymphoid organs | Q28239995 | ||
Structure and function of the spleen | Q28264813 | ||
Cells in the marginal zone of the spleen | Q28294678 | ||
Differential antigen processing by dendritic cell subsets in vivo | Q29615177 | ||
CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. | Q33928441 | ||
Sensing pathogens and tuning immune responses | Q34308011 | ||
The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing | Q34310837 | ||
DEC-205 as a marker of dendritic cells with regulatory effects on CD8 T cell responses | Q34508459 | ||
Steady-state and inflammatory dendritic-cell development | Q34591334 | ||
The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture | Q34771172 | ||
Experimental models linking dendritic cell lineage, phenotype and function | Q34842329 | ||
Distinct dendritic cell subsets differentially regulate the class of immune response in vivo | Q34950113 | ||
Macrophage receptors and immune recognition | Q36072472 | ||
A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo. | Q36229330 | ||
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. | Q36367475 | ||
CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo | Q36367705 | ||
The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo | Q36370304 | ||
Development of dendritic-cell lineages | Q36854617 | ||
Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. | Q36858877 | ||
Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens | Q36983205 | ||
Demystifying the development of dendritic cell subtypes, a little | Q37139265 | ||
In vivo induction of immune responses to pathogens by conventional dendritic cells | Q37272227 | ||
Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells | Q38470868 | ||
Production of monoclonal antibodies that recognize the extracellular domain of mouse langerin/CD207. | Q40123089 | ||
Generation and application of new rat monoclonal antibodies against synthetic FLAG and OLLAS tags for improved immunodetection. | Q40367717 | ||
A conduit system distributes chemokines and small blood-borne molecules through the splenic white pulp | Q42109460 | ||
Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody | Q42937985 | ||
Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes | Q72256249 | ||
Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues | Q72256256 | ||
CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen | Q73520530 | ||
Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets | Q73785333 | ||
Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression | Q77725476 | ||
Expression of langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains | Q80545136 | ||
Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo | Q80825231 | ||
Dendritic cells in vivo: a key target for a new vaccine science | Q81980748 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
dendritic cell | Q506253 | ||
P1104 | number of pages | 6 | |
P304 | page(s) | 1524-1529 | |
P577 | publication date | 2009-01-23 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen | |
P478 | volume | 106 |
Q36452968 | A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo |
Q58657596 | A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3 |
Q34055422 | A protective role of murine langerin⁺ cells in immune responses to cutaneous vaccination with microneedle patches |
Q35192110 | A systems biology approach to the analysis of subset-specific responses to lipopolysaccharide in dendritic cells. |
Q27025806 | Adaptive immunity to fungi |
Q35164257 | Adaptive immunity to fungi. |
Q53264097 | Bone marrow involvement of Langerhans cell histiocytosis: immunohistochemical evaluation of bone marrow for CD1a, Langerin, and S100 expression. |
Q36949916 | Bridging channel dendritic cells induce immunity to transfused red blood cells |
Q48246976 | C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody Complexes |
Q40371989 | CD1- and CD1+ porcine blood dendritic cells are enriched for the orthologues of the two major mammalian conventional subsets |
Q33615124 | CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells |
Q35211997 | CD8α(+) dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes |
Q34573130 | Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. |
Q33608738 | Comparison of gene expression profiles between human and mouse monocyte subsets |
Q28394035 | Critical role of CCL22/CCR4 axis in the maintenance of immune homeostasis during apoptotic cell clearance by splenic CD8α(+) CD103(+) dendritic cells |
Q93338385 | Dendritic cell subsets in T cell programming: location dictates function |
Q27001738 | Dendritic cells in antifungal immunity and vaccine design |
Q50230453 | Differential Intrasplenic Migration of Dendritic Cell Subsets Tailors Adaptive Immunity. |
Q33838810 | Differential roles of lung dendritic cell subsets against respiratory virus infection |
Q37709827 | Disentangling the complexity of the skin dendritic cell network. |
Q40110838 | Distinct oxysterol requirements for positioning naïve and activated dendritic cells in the spleen |
Q40117729 | Dual role of monocyte-derived dendritic cells in Trypanosoma cruzi infection. |
Q24293019 | Dual specificity of Langerin to sulfated and mannosylated glycans via a single C-type carbohydrate recognition domain |
Q33591529 | Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells |
Q50263128 | Erythrophagocytosis by plasmacytoid dendritic cells and monocytes is enhanced during inflammation |
Q38148774 | Exploiting dendritic cells in the development of cancer vaccines |
Q28741462 | Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines |
Q40204301 | Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis. |
Q27026702 | F4/80 and the related adhesion-GPCRs |
Q29620142 | Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages |
Q42080355 | Generation of anti-human DEC205/CD205 monoclonal antibodies that recognize epitopes conserved in different mammals. |
Q53301956 | Heterogeneity in a mouse model of histiocytosis: transformation of Langerin+ dendritic cells, macrophages, and precursors. |
Q36446942 | Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes |
Q36182555 | Host Langerin (CD207) is a receptor for Yersinia pestis phagocytosis and promotes dissemination. |
Q37836489 | How to improve the immunogenicity of chemotherapy and radiotherapy |
Q38104772 | Human dendritic cells subsets as targets and vectors for therapy |
Q38341386 | Identification and putative roles of distinct subtypes of intestinal dendritic cells in neuroimmune communication: what can be learned from other organ systems? |
Q37011094 | IgE-mediated enhancement of CD4(+) T cell responses requires antigen presentation by CD8α(-) conventional dendritic cells. |
Q33760814 | Immune evasion by Yersinia enterocolitica: differential targeting of dendritic cell subpopulations in vivo |
Q34459335 | Immunologic characterization suggests reduced alloimmunization in a murine model of thalassemia intermedia |
Q37626826 | Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells |
Q34126278 | Inflammatory monocytes and neutrophils are licensed to kill during memory responses in vivo |
Q37700833 | Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. |
Q55527143 | Langerin+ CD8α+ Dendritic Cells Drive Early CD8+ T Cell Activation and IL-12 Production During Systemic Bacterial Infection. |
Q41888907 | Langerin, the "Catcher in the Rye": an important receptor for pathogens on Langerhans cells. |
Q64118720 | LangerinCD8 Dendritic Cells in the Splenic Marginal Zone: Not So Marginal After All |
Q34324243 | Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes |
Q33882051 | Molecular control of steady-state dendritic cell maturation and immune homeostasis |
Q34342500 | Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance |
Q45765060 | Neonatal macrophages express elevated levels of interleukin-27 that oppose immune responses |
Q37589059 | New insights into the molecular pathogenesis of langerhans cell histiocytosis |
Q42209520 | Nitric oxide regulates BAFF expression and T cell-independent antibody responses |
Q39763165 | Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination. |
Q58544360 | Profiles in Science: Ralph M. Steinman, 2011 Nobelist for Physiology or Medicine |
Q28251005 | Recent advances in the understanding of Langerhans cell histiocytosis |
Q50243741 | Red blood cells with elevated cytoplasmic Ca(2+) are primarily taken up by splenic marginal zone macrophages and CD207+ dendritic cells |
Q54265746 | Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy. |
Q45875060 | Shutdown of immunological priming and presentation after in vivo administration of adenovirus |
Q35779708 | Signaling by myeloid C-type lectin receptors in immunity and homeostasis |
Q35785681 | Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses |
Q51792965 | Some active areas of DC research and their medical potential |
Q51013895 | Splenic CD8α⁺ dendritic cells undergo rapid programming by cytosolic bacteria and inflammation to induce protective CD8⁺ T-cell memory. |
Q92060086 | Structure and function of the immune system in the spleen |
Q37833270 | Targeting human dendritic cell subsets for improved vaccines |
Q34009407 | Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy |
Q37831193 | Targeting skin dendritic cells to improve intradermal vaccination. |
Q38024308 | The bloodline of CD8α(+) dendritic cells |
Q29618424 | The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting |
Q37008376 | The mechanism of splenic invariant NKT cell activation dictates localization in vivo |
Q37810779 | The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs |
Q37826217 | Tolerogenic dendritic cells and their potential applications |
Q37933760 | Transcription factor networks in dendritic cell development. |
Q28509633 | Treml4, an Ig superfamily member, mediates presentation of several antigens to T cells in vivo, including protective immunity to HER2 protein |
Q34200732 | Unique proteomic signatures distinguish macrophages and dendritic cells |
Q34546637 | Unravelling mononuclear phagocyte heterogeneity |
Search more.